Campian JL (2026). [PMID: 41748622](https://pubmed.ncbi.nlm.nih.gov/41748622/). *Nat Commun*. [Clinical Trial Publication]
Kokossis D (2026). [PMID: 41549586](https://pubmed.ncbi.nlm.nih.gov/41549586/). *Pediatr Blood Cancer*. [Review / Meta-Analysis]
Colman H (2026). [PMID: 41325560](https://pubmed.ncbi.nlm.nih.gov/41325560/). *J Clin Oncol*. [Clinical Trial Publication]
Muraleedharan A (2026). [PMID: 41827859](https://pubmed.ncbi.nlm.nih.gov/41827859/). *Cells*. [Review / Meta-Analysis]
Bao Z (2026). [PMID: 41821581](https://pubmed.ncbi.nlm.nih.gov/41821581/). *Cancer Commun (Lond)*. [Clinical Trial Publication]
Lasica AB (2025). [PMID: 40440464](https://pubmed.ncbi.nlm.nih.gov/40440464/). *Neuro Oncol*. [Basic Science / Preclinical]
Alkhaibary A (2025). [PMID: 40315666](https://pubmed.ncbi.nlm.nih.gov/40315666/). *J Clin Neurosci*. [Case Report / Case Series]
Fernández-Gajardo R (2025). [PMID: 41044136](https://pubmed.ncbi.nlm.nih.gov/41044136/). *Sci Rep*. [Epidemiology / Natural History]
Ippen FM (2025). [PMID: 39530475](https://pubmed.ncbi.nlm.nih.gov/39530475/). *Neuro Oncol*. [Diagnostic / Biomarker]
Onishi S (2025). [PMID: 39636550](https://pubmed.ncbi.nlm.nih.gov/39636550/). *J Neurooncol*. [Diagnostic / Biomarker]
